Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane channel-like protein 6 (TMC6) is an integral membrane protein with 10 predicted transmembrane domains and large N- and C-terminal domains on opposite sides of the plasma membrane[1][5]. It is a member of the TMC family of proteins, most homologous to TMC8. TMC6 localizes primarily to the endoplasmic reticulum but can also be found at the plasma membrane and in other subcellular localizations, including the nuclear membrane and Golgi apparatus[4][5]. TMC6, together with TMC8, forms a complex with zinc transporter 1 (ZnT-1/SLC30A1) that regulates zinc fluxes in cells, particularly in keratinocytes and lymphocytes[4][5][6]. Mutations in TMC6 are a cause of epidermodysplasia verruciformis (EV), a rare skin disorder associated with increased susceptibility to cutaneous human papillomavirus (HPV) infection and a high risk of developing skin cancers[4][5]. Beyond its role in zinc homeostasis and immune defense, recent research demonstrates that TMC6 acts as a non-classical GPCR-like receptor in sensory neurons, involved in thermal pain sensation. It modulates the activity of the neuronal M channel (KCNQ2/KCNQ3), affecting membrane excitability and response to noxious heat[1][3][5]. Loss of TMC6 increases intracellular zinc, which can activate the M channel, leading to reduced neuronal excitability and altered heat sensitivity—making it a potential target for modulating chronic pain and nociception[3]. No approved drugs are currently known to directly target TMC6, nor are there established biomarkers or mechanisms of action outside its molecular and physiological interactions as described above. However, therapeutic approaches targeting TMC6 or its pathways may have implications in HPV susceptibility, cancer prevention, and chronic pain modulation. Notably, safety concerns would relate to its essential skin barrier and immune protective roles[5][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane channel-like protein 6 (TMC6).